MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 64 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $768,490 | -17.5% | 595,729 | -15.6% | 0.23% | -12.3% |
| Q2 2023 | $931,562 | +0.1% | 705,729 | -46.4% | 0.26% | -8.8% |
| Q1 2023 | $930,454 | -39.5% | 1,316,245 | -35.8% | 0.28% | -38.6% |
| Q4 2022 | $1,537,246 | +854.8% | 2,049,661 | +998.1% | 0.46% | +648.4% |
| Q3 2022 | $161,000 | – | 186,656 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 523,382 | $1,518,000 | 0.16% |
| Birchview Capital, LP | 77,570 | $231,000 | 0.15% |
| CSS LLC/IL | 78,207 | $233,000 | 0.02% |
| Perceptive Advisors | 179,419 | $534,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 683,356 | $1,982,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 15,961 | $46,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,738 | $5,000 | 0.00% |
| Renaissance Technologies | 166,123 | $495,000 | 0.00% |
| UBS Group AG | 1,124 | $3,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 12,104 | $36,000 | 0.00% |